Technology News and Research

RSS

Envy Medical secures new growth capital from HCP & Company

Envy Medical, Inc., a leader in professional skincare products and services, announced today that it has secured new growth capital from HCP & Company, a middle-market private equity firm headquartered in Chicago.

4 Jun 2014

Painless wearable microneedle device can analyze electrolyte levels on the spot

Patients trying to navigate today's complex medical system with its costly laboratory analyses might prefer a pain-free home diagnostic device, worn on the wrist, that can analyze, continuously record and immediately remedy low electrolyte levels.

4 Jun 2014

KineMed renews non-exclusive research collaboration with Pfizer

KineMed Inc. today announced the renewal of a non-exclusive research collaboration with Pfizer Inc. for the advancement of novel approaches in metabolic disease, in particular Type II diabetes.

4 Jun 2014

Glenmark Pharmaceuticals opens new monoclonal antibody manufacturing facility in Switzerland

Glenmark Pharmaceuticals S.A (GPSA), a wholly-owned subsidiary of Glenmark Pharmaceuticals Limited, India (GPL), announced the opening of its new cGMP compliant monoclonal antibody manufacturing facility in La Chaux-de-Fonds, Switzerland. T

4 Jun 2014

LUMEDX, Scientific Software Solutions to create Comprehensive Congenital Cardiac Information System

LUMEDX Corporation, a leading provider of cloud-based cardiovascular imaging and information systems (CVIS), and Scientific Software Solutions, Inc., (SSS), maker of PedCath congenital catheterization (cath) reporting software, announced today that they are partnering to create an innovative solution for congenital cardiac data and image management.

4 Jun 2014

Propak Asia 2014 to be held at BITEC on June 11-14

ProPak Asia is Asia's No. 1 international food, drink and pharmaceutical processing, filling and packaging technology event, to take place for its successful 22nd edition on 11 to 14 June at Bangkok International Trade and Exhibition Centre (BITEC).

4 Jun 2014

Provectus’ PV-10 data for intralesional treatment of solid tumors presented at ASCO annual meeting

Provectus Biopharmaceuticals, Inc., a development-stage oncology and dermatology biopharmaceutical company, announced today that data on its investigational agent PV-10 for intralesional (IL) treatment of solid tumors were featured in two presentations in the Poster Highlights Session, Melanoma/Skin Cancers, on June 2, 2014 during the American Society of Clinical Oncology (ASCO) annual meeting in Chicago, IL.

4 Jun 2014

New technology can non-invasively image human lymphatic system

The human lymphatic system is an important but poorly understood circulatory system consisting of tiny vessels spread throughout the body.

4 Jun 2014

New process to help select personalized treatment options for patients with lung adenocarcinoma

Moffitt Cancer Center researchers, in collaboration with the Lung Cancer Mutation Consortium, have developed a process to analyze mutated genes in lung adenocarcinoma to help better select personalized treatment options for patients.

4 Jun 2014

NeuroVive extends collaboration with Hospices Civils de Lyon

NeuroVive is extending its collaboration with Hospices Civils de Lyon (HCL) and Professor Ovize, which broadens the scope of NeuroVive's cardiovascular business area and creates the right conditions for the company to retain its leading position in mitochondrial medicine.

4 Jun 2014

Region Skåne and Sectra sign six-year agreement

Region Skåne, one of Sweden's largest care providers, has signed a six-year agreement with IT and medical technology company Sectra.

4 Jun 2014

BenQ Solar launches high efficiency solutions for the European solar markets

To meet the thriving demand for high performance solar products, BenQ Solar, the leading solar solution brand of AU Optronics, announced today that it has successfully introduced high efficiency and reliable total solutions for the European residential and commercial solar markets.

4 Jun 2014

Researchers reproduce tumor chromosomal translocations in human cells

Scientists from the Spanish National Cancer Research Centre and the Spanish National Cardiovascular Research Centre have been able to reproduce, for the first time in human cells, chromosomal translocations associated with two types of cancer: acute myeloid leukaemia and Ewing's sarcoma.

4 Jun 2014

ConforMIS announces positive study results of iTotal implant at BASK meeting

ConforMIS, Inc., a medical device company pioneering patient-specific orthopaedic implants, today announced results from several clinical research studies highlighting the benefits of the iTotal® patient-specific total knee replacement.

4 Jun 2014

Endocrine Society publishes Clinical Practice Guideline for treatment of rare adrenal tumors

The Endocrine Society today issued a Clinical Practice Guideline (CPG) for the diagnosis and treatment of two types of rare adrenal tumors - pheochromocytomas and paragangliomas - that can raise the risk of cardiovascular disease and even death if left untreated.

4 Jun 2014

Study results suggest growing support for patient-centered care management

Primary care doctors practicing in a model of coordinated, team-based care that leverages health information technology are more likely to give patients recommended preventive screening and appropriate tests than physicians working in other settings, according to research published today in the Annals of Internal Medicine.

4 Jun 2014

Autifony Therapeutics awarded £2.2 million to progress first-in-class drug for tinnitus into Phase IIa study

Autifony Therapeutics Limited (“Autifony”), which is pioneering the development of novel pharmaceutical treatments for hearing disorders, today announced that it has been awarded funding of £2.2 million towards a Phase IIa clinical trial in tinnitus patients with its lead compound AUT00063, by the UK’s innovation agency, the Technology Strategy Board.

4 Jun 2014

Cornell researchers take new approach to screening aggressive cancer cells

Not all cancer cells are created equal - some stay put in the primary tumor, while others move and invade elsewhere. A major goal for cancer research is predicting which cells will metastasize, and why.

4 Jun 2014

UK makes £5.64M investment in most advanced crystallography technology

The UK's structural biology community will have access to the most advanced crystallography technology in the world thanks to a - £5.64M investment from UK research funders.

3 Jun 2014

AUO Optronics to showcase innovative display solutions at SID Display Week

AU Optronics Corp. ("AUO" or the "Company") announced today that it will participate in Display Week 2014 in San Diego from June 3 to 5. Organized by SID (The Society for Information Display), Display Week is the largest professional display exhibition in the United States.

3 Jun 2014